207 related articles for article (PubMed ID: 28209529)
1. Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause.
Staller K; Townsend MK; Khalili H; Mehta R; Grodstein F; Whitehead WE; Matthews CA; Kuo B; Chan AT
Gastroenterology; 2017 Jun; 152(8):1915-1921.e1. PubMed ID: 28209529
[TBL] [Abstract][Full Text] [Related]
2. Physical Activity, BMI, and Risk of Fecal Incontinence in the Nurses' Health Study.
Staller K; Song M; Grodstein F; Matthews CA; Whitehead WE; Kuo B; Chan AT; Townsend MK
Clin Transl Gastroenterol; 2018 Oct; 9(10):200. PubMed ID: 30356052
[TBL] [Abstract][Full Text] [Related]
3. Increased Long-term Dietary Fiber Intake Is Associated With a Decreased Risk of Fecal Incontinence in Older Women.
Staller K; Song M; Grodstein F; Whitehead WE; Matthews CA; Kuo B; Chan AT
Gastroenterology; 2018 Sep; 155(3):661-667.e1. PubMed ID: 29758215
[TBL] [Abstract][Full Text] [Related]
4. Association between menopausal hormone therapy and the risk of gastric cancer: A Korean nationwide population-based cohort study.
Han KH; Choi YJ; Han K; Shin CM; Park NH; Lee DH
Maturitas; 2024 Jun; 184():107960. PubMed ID: 38460415
[TBL] [Abstract][Full Text] [Related]
5. Hormone therapy increases risk of ulcerative colitis but not Crohn's disease.
Khalili H; Higuchi LM; Ananthakrishnan AN; Manson JE; Feskanich D; Richter JM; Fuchs CS; Chan AT
Gastroenterology; 2012 Nov; 143(5):1199-1206. PubMed ID: 22841783
[TBL] [Abstract][Full Text] [Related]
6. Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N cohort.
Engel P; Fabre A; Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
Am J Epidemiol; 2011 Jul; 174(1):12-21. PubMed ID: 21555715
[TBL] [Abstract][Full Text] [Related]
7. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition.
Bakken K; Fournier A; Lund E; Waaseth M; Dumeaux V; Clavel-Chapelon F; Fabre A; Hémon B; Rinaldi S; Chajes V; Slimani N; Allen NE; Reeves GK; Bingham S; Khaw KT; Olsen A; Tjønneland A; Rodriguez L; Sánchez MJ; Etxezarreta PA; Ardanaz E; Tormo MJ; Peeters PH; van Gils CH; Steffen A; Schulz M; Chang-Claude J; Kaaks R; Tumino R; Gallo V; Norat T; Riboli E; Panico S; Masala G; González CA; Berrino F
Int J Cancer; 2011 Jan; 128(1):144-56. PubMed ID: 20232395
[TBL] [Abstract][Full Text] [Related]
8. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal hormone therapy and incident urinary incontinence in middle-aged women.
Townsend MK; Curhan GC; Resnick NM; Grodstein F
Am J Obstet Gynecol; 2009 Jan; 200(1):86.e1-5. PubMed ID: 19019333
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study.
Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Savoye I; Boutron-Ruault MC; Fournier A; Kvaskoff M
Int J Cancer; 2019 Oct; 145(7):1754-1767. PubMed ID: 30671928
[TBL] [Abstract][Full Text] [Related]
11. Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health Study.
Burke KE; Ananthakrishnan AN; Lochhead P; Liu PH; Olen O; Ludvigsson JF; Richter JM; Tworoger SS; Chan AT; Khalili H
Gastroenterology; 2018 Dec; 155(6):1764-1775.e2. PubMed ID: 30144433
[TBL] [Abstract][Full Text] [Related]
12. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
Beral V; Reeves G; Bull D; Green J;
J Natl Cancer Inst; 2011 Feb; 103(4):296-305. PubMed ID: 21278356
[TBL] [Abstract][Full Text] [Related]
14. Menopause and postmenopausal hormone therapy and risk of hearing loss.
Curhan SG; Eliassen AH; Eavey RD; Wang M; Lin BM; Curhan GC
Menopause; 2017 Sep; 24(9):1049-1056. PubMed ID: 28486246
[TBL] [Abstract][Full Text] [Related]
15. Menopausal Hormone Therapy and Risk of Diverticulitis.
Jovani M; Ma W; Joshi AD; Liu PH; Nguyen LH; Cao Y; Tam I; Wu K; Giovannucci EL; Chan AT; Strate LL
Am J Gastroenterol; 2019 Feb; 114(2):315-321. PubMed ID: 30730324
[TBL] [Abstract][Full Text] [Related]
16. Reproductive history and risk of colorectal cancer in postmenopausal women.
Zervoudakis A; Strickler HD; Park Y; Xue X; Hollenbeck A; Schatzkin A; Gunter MJ
J Natl Cancer Inst; 2011 May; 103(10):826-34. PubMed ID: 21447807
[TBL] [Abstract][Full Text] [Related]
17. Body fat distribution, menopausal hormone therapy and incident type 2 diabetes in postmenopausal women of the MESA study.
Ebong IA; Watson KE; Hairston KG; Carnethon MR; Ouyang P; Szklo M; Bertoni AG
Maturitas; 2016 Sep; 91():147-52. PubMed ID: 27451334
[TBL] [Abstract][Full Text] [Related]
18. Endometrial cancer risk with menopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
Yuk JS
Int J Gynaecol Obstet; 2023 Aug; 162(2):502-513. PubMed ID: 36964935
[TBL] [Abstract][Full Text] [Related]
19. [Menopause and risk of thromboembolic events. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
Hugon-Rodin J; Perol S; Plu-Bureau G
Gynecol Obstet Fertil Senol; 2021 May; 49(5):455-461. PubMed ID: 33757918
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormone therapy and asthma onset in the E3N cohort.
Romieu I; Fabre A; Fournier A; Kauffmann F; Varraso R; Mesrine S; Leynaert B; Clavel-Chapelon F
Thorax; 2010 Apr; 65(4):292-7. PubMed ID: 20142267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
